BioCentury
ARTICLE | Politics & Policy

FDA's Sherman leaving as OMP director

December 18, 2013 1:17 AM UTC

Rachel Sherman, director of the Office of Medical Policy (OMP) in FDA's Center for Drug Evaluation and Research (CDER), will retire in January, according to an agency spokesperson. Denise Hinton, director of OMP's Office of Medical Policy Initiatives, will serve as acting OMP director. ...